Allergan PLC (AGN)

AGN (NYSE:Drugs) EQUITY
$204.65
pos +1.99
+0.98%
Today's Range: 201.42 - 209.25 | AGN Avg Daily Volume: 2,005,800
Last Update: 09/22/17 - 4:00 PM EDT
Volume: 3,899,017
YTD Performance: -0.00%
Open: $202.50
Previous Close: $202.66
52 Week Range: $184.50 - $256.80
Oustanding Shares: 334,306,189
Market Cap: 70,204,299,690
6-Month Chart
TheStreet Ratings Grade for AGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 8 8 8
Moderate Buy 1 3 3 3
Hold 4 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.75 1.61 1.61 1.61
Latest Dividend: 0.70
Latest Dividend Yield: 1.33%
Dividend Ex-Date: 08/16/17
Price Earnings Ratio: -17.93
Price Earnings Comparisons:
AGN Sector Avg. S&P 500
-17.93 7.20 36.80
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-12.00% -15.09% -13.16%
GROWTH 12 Mo 3 Yr CAGR
Revenue -3.30 0.70 0.19
Net Income 282.20 0.20 0.00
EPS 281.40 -8.20 0.00
Earnings for AGN:
EBITDA 5.58B
Revenue 14.57B
Average Earnings Estimates
Qtr (09/17) Qtr (12/17) FY (12/17) FY (12/18)
Average Estimate $4.13 $4.71 $16.23 $17.93
Number of Analysts 17 17 17 18
High Estimate $4.44 $4.89 $16.40 $18.66
Low Estimate $3.91 $4.27 $16.07 $17.18
Prior Year $3.32 $3.90 $13.51 $16.23
Growth Rate (Year over Year) 24.29% 20.87% 20.14% 10.44%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

Adding to Some Longs Real Money Pro($)

I have added to the following longs today: Allergan (AGN) (at $211.25), Dillard's (DDS) (at $55.13).

Citigroup Still Loves Allergan Real Money Pro($)

Citigroup reiterates its buy on Allergan (AGN) ($280 price target).
Morgan Stanley has lowered Allergan (AGN) from overweight to neutral ( $228 price target), which is in marked contrast to the enthusiasm expres…

Going Large on Allergan Real Money Pro($)

Moved to large sized Allergan (AGN) long at $214.50  
And I think it's gonna be a long long time 'Till touch down brings me round again to find I'm not the man they think I am at ho…
While there is a rotational shift away from biotech (iShs Nasdaq Biotech (IBB) ) I can't explain the weakness seen yesterday afternoon and this…

Some Midday Observations Real Money Pro($)

  * Applied Optoelectronics (AAOI) is a standout - +$8. This can happen with a stock that has 19 million shares outstanding (and a flo…
JPMorgan reiterates its Allergan (AGN) buy this morning, citing the "highly attractive" core franchise, pipeline optionality and a strong "sum …
Allergan (AGN) acts badly for the second day in a row (-$4 or -2% on the day),  but I don't see any news that would explain the drop. …
Answering questions from the biotech mailbag.

Columnist Conversations

volatility is quite low here, and we could see some downsides here in the short term. ...
View Chart »  View in New Window »
this chart is showing great bullish signs here, we like this to take out the old high shortly. ...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.